Life sciences professionals will need to keep up with market demand for biologics and biosimilars.
Theresa Vuskovich
Advertisement
Articles by Theresa Vuskovich
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market
2
Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion
3
Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last
4
Novartis to Acquire Myricx Bio for $1.1 Billion
5